SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-011413
Filing Date
2011-02-10
Accepted
2011-02-10 08:01:43
Documents
3
Period of Report
2011-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g26066e8vk.htm 8-K 13116
2 EX-99.1 g26066exv99w1.htm EX-99.1 40195
3 GRAPHIC g26066g2606600.gif GRAPHIC 3525
  Complete submission text file 0000950123-11-011413.txt   59890
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 11589380
SIC: 2836 Biological Products, (No Diagnostic Substances)